Mycotopia Therapies, Inc.
TPIA · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $228 | $238 | $2,600 | $30,044 |
| - Cash | $185 | $279 | $386 | $1,268 |
| + Debt | $1,265 | $1,091 | $655 | $749 |
| Enterprise Value | $1,307 | $1,050 | $2,869 | $29,525 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$61 | -$1 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,635 | -$556 | -$1,735 | -$4,987 |
| % Margin | – | – | – | – |
| Net Income | -$1,848 | -$1,181 | -$3,627 | -$2,972 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.14 | -0 | -0.25 | -0.22 |
| % Growth | -139,900% | 100% | -13.6% | – |
| Operating Cash Flow | -$259 | -$107 | -$657 | -$235 |
| Capital Expenditures | $0 | $0 | $0 | -$3 |
| Free Cash Flow | -$259 | -$107 | -$657 | -$238 |